About NexusCRO
NexusCRO is a Healthcare company based in Mumbai (India) founded in 1995. It operates as a functions as a full-service clinical research organization, supporting pharmaceutical and biotech trials. It operates on a B2B model. The company has 51 employees. Its Indian entity Nexus Central Lab Services Private Limited reported revenue of ₹8.45 Cr. Its focus areas include Biotechnology and Pharmaceuticals, Clinical Research and Contract Organization. Its competitors include Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global and 3 more; 3 of its 8 listed competitors have raised funding.
Company details
NexusCRO functions as a full-service clinical research organization, supporting pharmaceutical and biotech trials through providing healthcare solutions, biotechnology and pharmaceuticals, clinical research, and contract organization. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Mumbai, India
- Employees 51
- SectorsHealthcare
- Email••••••••
- Website nexuscro.com
- Legal Name Nexus Central Lab Services Private Limited
- Date of Incorporation 18 Sep, 2007
- Jurisdiction Navi Mumbai, Maharashtra, India
- Annual Revenue₹8.45 Cr
FY 2025 · +8% YoY
- Net Profit₹1.01 Cr
FY 2025 · 12% margin
- EBITDA₹2.24 Cr
FY 2025 · 27% margin
- Employee Count51
Associated legal entities of NexusCRO
NexusCRO operates through Nexus Central Lab Services Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nexus Central Lab Services Private Limited CIN U85195MH2007PTC174247 | Active | 18 Sep 2007 | Navi Mumbai, Maharashtra | ₹8.5 Cr | 51 | 2 | View details |
Board of directors of Nexus Central Lab Services Private Limited (NexusCRO)
Nexus Central Lab Services Private Limited is the primary company behind NexusCRO. The board of Nexus Central Lab Services Private Limited currently have 2 directors; the longest-serving is Meghna Amit Bhatt, appointed in 2007. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Meghna Amit Bhatt DIN 01070094 | Managing Director | 18 Sep 2007 | 19 yrs 1 mo | Nexus Central Lab Services Private Limited |
| Amit Bhatt DIN 07859111 | Director | 22 Mar 2018 | 8 yrs 6 mo | Nexus Central Lab Services Private Limited |
Financials of NexusCRO
Figures of Nexus Central Lab Services Private Limited, the primary company behind NexusCRO, for FY 2025. Revenue was ₹8.45 Cr (+8% year on year). Net profit was ₹1.01 Cr (12% margin). EBITDA was ₹2.24 Cr (27% margin). Revenue has grown at a compounded annual rate of +7% over three years and +5% over five years.
- ₹8.45 CrRevenue · FY 2025 · +8% YoY
- ₹1.01 CrNet profit · 12% margin
- ₹2.24 CrEBITDA · 27% margin
- ₹1 LakhPaid-up capital
- 51Employees (provident fund records)
- +7%Revenue CAGR, 3 years
- +5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Nexus Central Lab Services Private Limited are on its company page.
Detailed financial statements for NexusCRO
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of NexusCRO
NexusCRO has 8 listed competitors in our database, 3 of them funded. They include Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| emmes.com | 1977 | United States | – | 195 | Outsourced contract research organization services are provided to clients. | |
| syneoshealth.com | 1984 | Raleigh, United States | – | 29,395 | CRO clinical development services are provided by Syneos Health. | |
| veristat.com | 1994 | Southborough, United States | – | 7 | Clinical trials and regulatory submissions are supported as a CRO. | |
| clinchoice.com | 1995 | Fort Washington, United States | $212M | 478 | CRO focused on data management, regulatory affairs and consulting services | |
| wcct.com | 1998 | Cypress, United States | $17M | 229 | Full-service CRO expertise in influenza and oncology research is offered. | |
| celgene.com | 1986 | Summit, United States | $45M | 4,891 | Therapies for cancer and inflammatory diseases are developed. | |
| hvivo.com | 1998 | London, United Kingdom | – | 133 | Provider of cell based assays, field trial, and molecular services for biopharma sector | |
| parexel.com | 1983 | Waltham, United States | – | – | Full-service clinical research organization services are provided globally by Parexel. |
Detailed competitors of NexusCRO
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical Trials & Research Tech
10 companies that operate in the same segment as NexusCRO (Clinical Trials & Research Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 617.6 M | – | 252 | |
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | – | 22 | |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | – | USD 50.52 M | 902 | |
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | – | USD 4.22 M | 228 | |
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | – | 25 | |
Laboratory focused on biotechnology & molecule research services | 2018 | Cambridge, Massachusetts, United States | USD 32.68 M | – | – | |
Laboratory delivers discovery & research in nuclear and particle physics | 1947 | United States | – | – | 2,436 | |
Research and manufacturing of hemp products are conducted by BRC. | 2017 | Monterey, California, United States | USD 25.26 M | – | 16 | |
Genome sequencing studies are conducted for medical research purposes. | 2020 | Cambridge, Cambridgeshire, United Kingdom | USD 11.26 M | – | 12 | |
Novel immunotherapy therapeutic targets are discovered through laboratory research. | 2019 | Branford, Connecticut, United States | USD 92 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NexusCRO
NexusCRO was founded in 1995.
NexusCRO is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
NexusCRO has 51 employees.
The primary company behind NexusCRO, Nexus Central Lab Services Private Limited, reported revenue of ₹8.45 Cr for FY 2025, up 8% year on year.
NexusCRO functions as a full-service clinical research organization, supporting pharmaceutical and biotech trials through providing healthcare solutions, biotechnology and pharmaceuticals, clinical research, and contract organization. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
NexusCRO's top competitors include Emmes, Syneos Health and ClinChoice.
NexusCRO operates through Nexus Central Lab Services Private Limited.
The legal entities of NexusCRO currently have 2 directors, including Meghna Amit Bhatt, Amit Bhatt.